Clinical Trial Update: Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of DRibbles vaccine immunotherapy for patients with definitively treated stage III non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DRibbles vaccine

Snippet

Sponsor: UbiVac | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED